{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T01:59:38Z","timestamp":1787104778371,"version":"build-2736575974"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:00:00Z","timestamp":1493769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nicotine modulates neuroplasticity and improves cognitive functions in animals and humans. In the brain of smoking individuals, calcium-dependent plasticity induced by non-invasive brain stimulation methods such as transcranial direct current stimulation (tDCS) and paired associative stimulation (PAS) is impaired by nicotine withdrawal, but partially re-established after nicotine re-administration. In order to investigate the underlying mechanism further, we tested the impact of the \u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>2<\/jats:sub>-nicotinic receptor partial agonist varenicline on focal and non-focal plasticity in smokers during nicotine withdrawal, induced by PAS and tDCS, respectively. We administered low (0.3\u2009mg) and high (1.0\u2009mg) single doses of varenicline or placebo medication before stimulation over the left motor cortex of 20 healthy smokers under nicotine withdrawal. Motor cortex excitability was monitored by single-pulse transcranial magnetic stimulation-induced motor evoked potential amplitudes for 36\u2009hours after plasticity induction. Stimulation-induced plasticity was absent under placebo medication, whereas it was present in all conditions under high dose. Low dose restituted only tDCS-induced non-focal plasticity, producing no significant impact on focal plasticity. High dose varenicline also prolonged inhibitory plasticity. These results are comparable to the impact of nicotine on withdrawal-related impaired plasticity in smokers and suggest that \u03b1<jats:sub>4<\/jats:sub>\u03b2<jats:sub>2<\/jats:sub>nicotinic receptors are relevantly involved in plasticity deficits and restitution in smokers.<\/jats:p>","DOI":"10.1038\/s41598-017-01428-6","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T09:31:09Z","timestamp":1493199069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Compromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic \u03b14\u03b22-receptor partial agonist varenicline"],"prefix":"10.1038","volume":"7","author":[{"given":"G.","family":"Batsikadze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Grundey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-F.","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,3]]},"reference":[{"key":"1428_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00213-009-1571-y","volume":"205","author":"B Froeliger","year":"2009","unstructured":"Froeliger, B., Gilbert, D. G. & McClernon, F. J. Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl) 205, 625\u2013633, doi:10.1007\/s00213-009-1571-y (2009).","journal-title":"Psychopharmacology (Berl)"},{"key":"1428_CR2","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-010-1848-1","volume":"210","author":"SJ Heishman","year":"2010","unstructured":"Heishman, S. J., Kleykamp, B. A. & Singleton, E. G. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210, 453\u2013469, doi:10.1007\/s00213-010-1848-1 (2010).","journal-title":"Psychopharmacology (Berl)"},{"key":"1428_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/npp.2012.205","volume":"38","author":"RJ Mocking","year":"2013","unstructured":"Mocking, R. J. et al. Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study. Neuropsychopharmacology 38, 476\u2013484, doi:10.1038\/npp.2012.205 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/0269881104047273","volume":"18","author":"KA Sacco","year":"2004","unstructured":"Sacco, K. A., Bannon, K. L. & George, T. P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 18, 457\u2013474, doi:10.1177\/0269881104047273 (2004).","journal-title":"J Psychopharmacol"},{"key":"1428_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/hup.470080303","volume":"8","author":"N Sherwood","year":"1993","unstructured":"Sherwood, N. Effects of Nicotine on Human Psychomotor Performance. Hum Psychopharm Clin 8, 155\u2013184, doi:10.1002\/hup.470080303 (1993).","journal-title":"Hum Psychopharm Clin"},{"key":"1428_CR6","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.euroneuro.2014.03.011","volume":"24","author":"P Niemegeers","year":"2014","unstructured":"Niemegeers, P. et al. The effects of nicotine on cognition are dependent on baseline performance. Eur Neuropsychopharmacol 24, 1015\u20131023, doi:10.1016\/j.euroneuro.2014.03.011 (2014).","journal-title":"Eur Neuropsychopharmacol"},{"key":"1428_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0143-4160(98)90056-2","volume":"24","author":"N Burnashev","year":"1998","unstructured":"Burnashev, N. Calcium permeability of ligand-gated channels. Cell Calcium 24, 325\u2013332, doi:10.1016\/S0143-4160(98)90056-2 (1998).","journal-title":"Cell Calcium"},{"key":"1428_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/aps.2009.39","volume":"30","author":"AN Placzek","year":"2009","unstructured":"Placzek, A. N., Zhang, T. A. & Dani, J. A. Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacol Sin 30, 752\u2013760, doi:10.1038\/aps.2009.39 (2009).","journal-title":"Acta Pharmacol Sin"},{"key":"1428_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","volume":"47","author":"JA Dani","year":"2007","unstructured":"Dani, J. A. & Bertrand, D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol 47, 699\u2013729, doi:10.1146\/annurev.pharmtox.47.120505.105214 (2007).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1428_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/ntr\/nts091","volume":"14","author":"JL Yakel","year":"2012","unstructured":"Yakel, J. L. Nicotinic ACh receptors in the hippocampus: role in excitability and plasticity. Nicotine Tob Res 14, 1249\u20131257, doi:10.1093\/ntr\/nts091 (2012).","journal-title":"Nicotine Tob Res"},{"key":"1428_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/npp.2010.227","volume":"36","author":"N Thirugnanasambandam","year":"2011","unstructured":"Thirugnanasambandam, N. et al. Nicotinergic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology 36, 879\u2013886, doi:10.1038\/npp.2010.227 (2011).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR12","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1093\/cercor\/bhu126","volume":"25","author":"G Batsikadze","year":"2015","unstructured":"Batsikadze, G., Paulus, W., Grundey, J., Kuo, M. F. & Nitsche, M. A. Effect of the Nicotinic alpha4beta2-receptor Partial Agonist Varenicline on Non-invasive Brain Stimulation-Induced Neuroplasticity in the Human Motor Cortex. Cereb Cortex 25, 3249\u20133259, doi:10.1093\/cercor\/bhu126 (2015).","journal-title":"Cereb Cortex"},{"key":"1428_CR13","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1523\/JNEUROSCI.3660-11.2012","volume":"32","author":"J Grundey","year":"2012","unstructured":"Grundey, J. et al. Neuroplasticity in cigarette smokers is altered under withdrawal and partially restituted by nicotine exposition. J Neurosci 32, 4156\u20134162, doi:10.1523\/JNEUROSCI.3660-11.2012 (2012).","journal-title":"J Neurosci"},{"key":"1428_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/cercor\/bhv252","author":"MD Lugon","year":"2015","unstructured":"Lugon, M. D. et al. Mechanisms of Nicotinic Modulation of Glutamatergic Neuroplasticity in Humans. Cereb Cortex\u00a027, 544\u2013553,\u00a0doi:10.1093\/cercor\/bhv252 (2017).","journal-title":"Cereb Cortex"},{"key":"1428_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3389\/fnhum.2013.00823","volume":"7","author":"RG Carson","year":"2013","unstructured":"Carson, R. G. & Kennedy, N. C. Modulation of human corticospinal excitability by paired associative stimulation. Front Hum Neurosci 7, 823, doi:10.3389\/fnhum.2013.00823 (2013).","journal-title":"Front Hum Neurosci"},{"key":"1428_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.brs.2008.06.004","volume":"1","author":"MA Nitsche","year":"2008","unstructured":"Nitsche, M. A. et al. Transcranial direct current stimulation: State of the art 2008. Brain stimulation 1, 206\u2013223, doi:10.1016\/j.brs.2008.06.004 (2008).","journal-title":"Brain stimulation"},{"key":"1428_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1152\/jn.1965.28.1.166","volume":"28","author":"DP Purpura","year":"1965","unstructured":"Purpura, D. P. & McMurtry, J. G. Intracellular Activities and Evoked Potential Changes during Polarization of Motor Cortex. J Neurophysiol 28, 166\u2013185 (1965).","journal-title":"J Neurophysiol"},{"key":"1428_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biopsych.2004.10.022","volume":"57","author":"LK Jacobsen","year":"2005","unstructured":"Jacobsen, L. K. et al. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57, 56\u201366, doi:10.1016\/j.biopsych.2004.10.022 (2005).","journal-title":"Biol Psychiatry"},{"key":"1428_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00213-013-3089-6","volume":"229","author":"KA Wesnes","year":"2013","unstructured":"Wesnes, K. A., Edgar, C. J., Kezic, I., Salih, H. M. & de Boer, P. Effects of nicotine withdrawal on cognition in a clinical trial setting. Psychopharmacology (Berl) 229, 133\u2013140, doi:10.1007\/s00213-013-3089-6 (2013).","journal-title":"Psychopharmacology (Berl)"},{"key":"1428_CR20","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00213-015-3880-7","volume":"232","author":"J Grundey","year":"2015","unstructured":"Grundey, J. et al. Double dissociation of working memory and attentional processes in smokers and non-smokers with and without nicotine. Psychopharmacology (Berl) 232, 2491\u20132501, doi:10.1007\/s00213-015-3880-7 (2015).","journal-title":"Psychopharmacology (Berl)"},{"key":"1428_CR21","doi-asserted-by":"publisher","unstructured":"Ashare, R. L., Falcone, M. & Lerman, C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology 76 Pt B, 581\u2013591, 10.1016\/j.neuropharm.2013.04.034 (2014).","DOI":"10.1016\/j.neuropharm.2013.04.034"},{"key":"1428_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.biopsych.2010.01.016","volume":"67","author":"J Loughead","year":"2010","unstructured":"Loughead, J. et al. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 67, 715\u2013721, doi:10.1016\/j.biopsych.2010.01.016 (2010).","journal-title":"Biol Psychiatry"},{"key":"1428_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fphar.2012.00186","volume":"3","author":"J Grundey","year":"2012","unstructured":"Grundey, J. et al. Rapid effect of nicotine intake on neuroplasticity in non-smoking humans. Front Pharmacol 3, 186, doi:10.3389\/fphar.2012.00186 (2012).","journal-title":"Front Pharmacol"},{"key":"1428_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/mol.106.025130","volume":"70","author":"KB Mihalak","year":"2006","unstructured":"Mihalak, K. B., Carroll, F. I. & Luetje, C. W. Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70, 801\u2013805, doi:10.1124\/mol.106.025130 (2006).","journal-title":"Mol Pharmacol"},{"key":"1428_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0028-3932(71)90067-4","volume":"9","author":"RC Oldfield","year":"1971","unstructured":"Oldfield, R. C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9, 97\u2013113, doi:10.1016\/0028-3932(71)90067-4 (1971).","journal-title":"Neuropsychologia"},{"key":"1428_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. & Fagerstrom, K. O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86, 1119\u20131127, doi:10.1111\/add.1991.86.issue-9 (1991).","journal-title":"Br J Addict"},{"key":"1428_CR27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0022-3565(25)33068-5","volume":"221","author":"NL Benowitz","year":"1982","unstructured":"Benowitz, N. L., Jacob, P. 3rd, Jones, R. T. & Rosenberg, J. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221, 368\u2013372 (1982).","journal-title":"J Pharmacol Exp Ther"},{"key":"1428_CR28","doi-asserted-by":"crossref","unstructured":"Nitsche, M. A. et al. Level of action of cathodal DC polarisation induced inhibition of the human motor cortex. Clin Neurophysiol 114, 600\u2013604, doi:S1388245702004121 (2003).","DOI":"10.1016\/S1388-2457(02)00412-1"},{"key":"1428_CR29","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.57.10.1899","volume":"57","author":"MA Nitsche","year":"2001","unstructured":"Nitsche, M. A. & Paulus, W. Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans. Neurology 57, 1899\u20131901, doi:10.1212\/WNL.57.10.1899 (2001).","journal-title":"Neurology"},{"issue":"Pt 3","key":"1428_CR30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/brain\/123.3.572","volume":"123","author":"K Stefan","year":"2000","unstructured":"Stefan, K., Kunesch, E., Cohen, L. G., Benecke, R. & Classen, J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain 123(Pt 3), 572\u2013584, doi:10.1093\/brain\/123.3.572 (2000).","journal-title":"Brain"},{"key":"1428_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1152\/jn.00383.2003","volume":"92","author":"K Stefan","year":"2004","unstructured":"Stefan, K., Wycislo, M. & Classen, J. Modulation of associative human motor cortical plasticity by attention. J Neurophysiol 92, 66\u201372, doi:10.1152\/jn.00383.2003 (2004).","journal-title":"J Neurophysiol"},{"key":"1428_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/COPD.S1848","volume":"3","author":"UM Mohanasundaram","year":"2008","unstructured":"Mohanasundaram, U. M., Chitkara, R. & Krishna, G. Smoking cessation therapy with varenicline. Int J Chron Obstruct Pulmon Dis 3, 239\u2013251, doi:10.2147\/COPD (2008).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1428_CR33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1124\/dmd.105.006767","volume":"34","author":"RS Obach","year":"2006","unstructured":"Obach, R. S. et al. Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos 34, 121\u2013130, doi:10.1124\/dmd.105.006767 (2006).","journal-title":"Drug Metab Dispos"},{"key":"1428_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2165\/11537850-000000000-00000","volume":"49","author":"HM Faessel","year":"2010","unstructured":"Faessel, H. M. et al. A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation. Clin Pharmacokinet 49, 799\u2013816, doi:10.2165\/11537850-000000000-00000 (2010).","journal-title":"Clin Pharmacokinet"},{"key":"1428_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1177\/0091270006290669","volume":"46","author":"HM Faessel","year":"2006","unstructured":"Faessel, H. M. et al. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers. J Clin Pharmacol 46, 991\u2013998, doi:10.1177\/0091270006290669 (2006).","journal-title":"J Clin Pharmacol"},{"key":"1428_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fninf.2014.00016","volume":"8","author":"SJ Guzman","year":"2014","unstructured":"Guzman, S. J., Schlogl, A. & Schmidt-Hieber, C. Stimfit: quantifying electrophysiological data with Python. Front Neuroinform 8, 16, doi:10.3389\/fninf.2014.00016 (2014).","journal-title":"Front Neuroinform"},{"key":"1428_CR37","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/ntr\/nts018","volume":"14","author":"K Fagerstrom","year":"2012","unstructured":"Fagerstrom, K., Russ, C., Yu, C. R., Yunis, C. & Foulds, J. The Fagerstrom Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data. Nicotine Tob Res 14, 1467\u20131473, doi:10.1093\/ntr\/nts018 (2012).","journal-title":"Nicotine Tob Res"},{"key":"1428_CR38","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/019394502762477004","volume":"24","author":"CM Musil","year":"2002","unstructured":"Musil, C. M., Warner, C. B., Yobas, P. K. & Jones, S. L. A comparison of imputation techniques for handling missing data. West J Nurs Res 24, 815\u2013829, doi:10.1177\/019394502762477004 (2002).","journal-title":"West J Nurs Res"},{"key":"1428_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1207\/s15327906mbr3304_5","volume":"33","author":"JL Schafer","year":"1998","unstructured":"Schafer, J. L. & Olsen, M. K. Multiple Imputation for Multivariate Missing-Data Problems: A Data Analyst\u2019s Perspective. Multivariate Behav Res 33, 545\u2013571, doi:10.1207\/s15327906mbr3304_5 (1998).","journal-title":"Multivariate Behav Res"},{"key":"1428_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1113\/jphysiol.2003.049916","volume":"553","author":"MA Nitsche","year":"2003","unstructured":"Nitsche, M. A. et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 553, 293\u2013301, doi:10.1113\/jphysiol.2003.049916 (2003).","journal-title":"J Physiol"},{"key":"1428_CR41","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1152\/jn.00900.2002","volume":"89","author":"A Wolters","year":"2003","unstructured":"Wolters, A. et al. A temporally asymmetric Hebbian rule governing plasticity in the human motor cortex. J Neurophysiol 89, 2339\u20132345, doi:10.1152\/jn.00900.2002 (2003).","journal-title":"J Neurophysiol"},{"key":"1428_CR42","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1469-7793.2001.0285f.x","volume":"532","author":"JE Lisman","year":"2001","unstructured":"Lisman, J. E. Three Ca2+ levels affect plasticity differently: the LTP zone, the LTD zone and no man\u2019s land. J Physiol 532, 285\u2013285, doi:10.1111\/tjp.2001.532.issue-2 (2001).","journal-title":"J Physiol"},{"key":"1428_CR43","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.tips.2004.04.006","volume":"25","author":"F Dajas-Bailador","year":"2004","unstructured":"Dajas-Bailador, F. & Wonnacott, S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25, 317\u2013324, doi:10.1016\/j.tips.2004.04.006 (2004).","journal-title":"Trends Pharmacol Sci"},{"key":"1428_CR44","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1254\/jphs.93.180","volume":"93","author":"S Matsuyama","year":"2003","unstructured":"Matsuyama, S. & Matsumoto, A. Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP. J Pharmacol Sci 93, 180\u2013187, doi:10.1254\/jphs.93.180 (2003).","journal-title":"J Pharmacol Sci"},{"key":"1428_CR45","first-page":"429","volume":"21","author":"J He","year":"2000","unstructured":"He, J., Deng, C. Y., Chen, R. Z., Zhu, X. N. & Yu, J. P. Long-term potentiation induced by nicotine in CA1 region of hippocampal slice is Ca(2+)-dependent. Acta Pharmacol Sin 21, 429\u2013432 (2000).","journal-title":"Acta Pharmacol Sin"},{"key":"1428_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.pneurobio.2007.12.005","volume":"84","author":"MR Picciotto","year":"2008","unstructured":"Picciotto, M. R., Addy, N. A., Mineur, Y. S. & Brunzell, D. H. It is not \u201ceither\/or\u201d: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol 84, 329\u2013342, doi:10.1016\/j.pneurobio.2007.12.005 (2008).","journal-title":"Prog Neurobiol"},{"key":"1428_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.brainresrev.2004.09.003","volume":"48","author":"H Wang","year":"2005","unstructured":"Wang, H. & Sun, X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 48, 420\u2013437, doi:10.1016\/j.brainresrev.2004.09.003 (2005).","journal-title":"Brain Res Brain Res Rev"},{"key":"1428_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0028-3908(97)00193-7","volume":"37","author":"PP Rowell","year":"1998","unstructured":"Rowell, P. P. & Duggan, D. S. Long-lasting inactivation of nicotinic receptor function in vitro by treatment with high concentrations of nicotine. Neuropharmacology 37, 103\u2013111, doi:10.1016\/S0028-3908(97)00193-7 (1998).","journal-title":"Neuropharmacology"},{"key":"1428_CR49","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1471-4159.1991.tb11403.x","volume":"56","author":"RJ Lukas","year":"1991","unstructured":"Lukas, R. J. Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671\/RD human clonal line. J Neurochem 56, 1134\u20131145, doi:10.1111\/jnc.1991.56.issue-4 (1991).","journal-title":"J Neurochem"},{"key":"1428_CR50","doi-asserted-by":"publisher","unstructured":"D\u2019Souza, M. S. & Markou, A. The \u201cstop\u201d and \u201cgo\u201d of nicotine dependence: role of GABA and glutamate. Cold Spring Harb Perspect Med 3, doi:10.1101\/cshperspect.a012146 (2013).","DOI":"10.1101\/cshperspect.a012146"},{"key":"1428_CR51","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1124\/jpet.103.052027","volume":"306","author":"PJ Kenny","year":"2003","unstructured":"Kenny, P. J., Gasparini, F. & Markou, A. Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)\/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats. J Pharmacol Exp Ther 306, 1068\u20131076, doi:10.1124\/jpet.103.052027 (2003).","journal-title":"J Pharmacol Exp Ther"},{"key":"1428_CR52","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.neuropharm.2008.12.008","volume":"56","author":"H Tan","year":"2009","unstructured":"Tan, H., Bishop, S. F., Lauzon, N. M., Sun, N. & Laviolette, S. R. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine\u2019s rewarding and aversive effects. Neuropharmacology 56, 741\u2013751, doi:10.1016\/j.neuropharm.2008.12.008 (2009).","journal-title":"Neuropharmacology"},{"key":"1428_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1440-1819.2008.01822.x","volume":"62","author":"J Semba","year":"2008","unstructured":"Semba, J. & Wakuta, M. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion. Psychiatry and clinical neurosciences 62, 435\u2013441, doi:10.1111\/j.1440-1819.2008.01822.x (2008).","journal-title":"Psychiatry and clinical neurosciences"},{"key":"1428_CR54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neulet.2011.01.015","volume":"491","author":"T Kivinummi","year":"2011","unstructured":"Kivinummi, T., Kaste, K., Rantamaki, T., Castren, E. & Ahtee, L. Alterations in BDNF and phospho-CREB levels following chronic oral nicotine treatment and its withdrawal in dopaminergic brain areas of mice. Neuroscience letters 491, 108\u2013112, doi:10.1016\/j.neulet.2011.01.015 (2011).","journal-title":"Neuroscience letters"},{"key":"1428_CR55","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/npp.2015.270","volume":"41","author":"HI Kuo","year":"2016","unstructured":"Kuo, H. I. et al. Chronic Enhancement of Serotonin Facilitates Excitatory Transcranial Direct Current Stimulation-Induced Neuroplasticity. Neuropsychopharmacology 41, 1223\u20131230, doi:10.1038\/npp.2015.270 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR56","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/cercor\/bhm098","volume":"18","author":"MF Kuo","year":"2008","unstructured":"Kuo, M. F., Paulus, W. & Nitsche, M. A. Boosting focally-induced brain plasticity by dopamine. Cereb Cortex 18, 648\u2013651, doi:10.1093\/cercor\/bhm098 (2008).","journal-title":"Cereb Cortex"},{"key":"1428_CR57","doi-asserted-by":"publisher","first-page":"22180","DOI":"10.1038\/srep22180","volume":"6","author":"MV Podda","year":"2016","unstructured":"Podda, M. V. et al. Anodal transcranial direct current stimulation boosts synaptic plasticity and memory in mice via epigenetic regulation of Bdnf expression. Sci Rep 6, 22180, doi:10.1038\/srep22180 (2016).","journal-title":"Sci Rep"},{"key":"1428_CR58","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra0809890","volume":"362","author":"NL Benowitz","year":"2010","unstructured":"Benowitz, N. L. Nicotine Addiction. New Engl J Med 362, 2295\u20132303, doi:10.1056\/NEJMra0809890 (2010).","journal-title":"New Engl J Med"},{"key":"1428_CR59","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1038\/nn1580","volume":"8","author":"JA Dani","year":"2005","unstructured":"Dani, J. A. & Harris, R. A. Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 8, 1465\u20131470, doi:10.1038\/nn1580 (2005).","journal-title":"Nat Neurosci"},{"key":"1428_CR60","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/FBP.0000000000000111","volume":"26","author":"E Yildirim","year":"2015","unstructured":"Yildirim, E., Connor, D. A. & Gould, T. J. ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6\/J mice. Behav Pharmacol 26, 241\u2013248, doi:10.1097\/FBP.0000000000000111 (2015).","journal-title":"Behav Pharmacol"},{"key":"1428_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nlm.2007.05.002","volume":"89","author":"GS Portugal","year":"2008","unstructured":"Portugal, G. S., Kenney, J. W. & Gould, T. J. Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol Learn Mem 89, 106\u2013113, doi:10.1016\/j.nlm.2007.05.002 (2008).","journal-title":"Neurobiol Learn Mem"},{"key":"1428_CR62","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1037\/a0012601","volume":"122","author":"JD Raybuck","year":"2008","unstructured":"Raybuck, J. D., Portugal, G. S., Lerman, C. & Gould, T. J. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL\/6 mice. Behav Neurosci 122, 1166\u20131171, doi:10.1037\/a0012601 (2008).","journal-title":"Behav Neurosci"},{"key":"1428_CR63","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.2741\/2424","volume":"12","author":"CE Adams","year":"2007","unstructured":"Adams, C. E. & Stevens, K. E. Evidence for a role of nicotinic acetylcholine receptors in schizophrenia. Front Biosci 12, 4755\u20134772, doi:10.2741\/2424 (2007).","journal-title":"Front Biosci"},{"key":"1428_CR64","first-page":"195","volume":"12","author":"S Leonard","year":"1998","unstructured":"Leonard, S. et al. Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci 12, 195\u2013201 (1998).","journal-title":"Restor Neurol Neurosci"},{"key":"1428_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","volume":"76","author":"J de Leon","year":"2005","unstructured":"de Leon, J. & Diaz, F. J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76, 135\u2013157, doi:10.1016\/j.schres.2005.02.010 (2005).","journal-title":"Schizophr Res"},{"key":"1428_CR66","doi-asserted-by":"publisher","first-page":"1021-+","DOI":"10.1016\/j.neubiorev.2005.02.006","volume":"29","author":"V Kumari","year":"2005","unstructured":"Kumari, V. & Postma, P. Nicotine use in schizophrenia: The self medication hypotheses. Neurosci Biobehav R 29, 1021\u2212+, doi:10.1016\/j.neubiorev.2005.02.006 (2005).","journal-title":"Neurosci Biobehav R"},{"key":"1428_CR67","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.brs.2011.08.004","volume":"5","author":"A Hasan","year":"2012","unstructured":"Hasan, A. et al. Impaired long-term depression in schizophrenia: a cathodal tDCS pilot study. Brain stimulation 5, 475\u2013483, doi:10.1016\/j.brs.2011.08.004 (2012).","journal-title":"Brain stimulation"},{"key":"1428_CR68","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/cercor\/bhm151","volume":"18","author":"MV Frantseva","year":"2008","unstructured":"Frantseva, M. V. et al. Evidence for impaired long-term potentiation in schizophrenia and its relationship to motor skill learning. Cereb Cortex 18, 990\u2013996, doi:10.1093\/cercor\/bhm151 (2008).","journal-title":"Cereb Cortex"},{"key":"1428_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbr.2011.05.017","volume":"224","author":"A Hasan","year":"2011","unstructured":"Hasan, A. et al. Dysfunctional long-term potentiation-like plasticity in schizophrenia revealed by transcranial direct current stimulation. Behav Brain Res 224, 15\u201322, doi:10.1016\/j.bbr.2011.05.017 (2011).","journal-title":"Behav Brain Res"},{"key":"1428_CR70","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/npp.2014.275","volume":"40","author":"W Strube","year":"2015","unstructured":"Strube, W. et al. Smoking restores impaired LTD-like plasticity in schizophrenia: a transcranial direct current stimulation study. Neuropsychopharmacology 40, 822\u2013830, doi:10.1038\/npp.2014.275 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR71","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.brs.2015.08.002","volume":"8","author":"J Brunelin","year":"2015","unstructured":"Brunelin, J., Hasan, A., Haesebaert, F., Nitsche, M. A. & Poulet, E. Nicotine Smoking Prevents the Effects of Frontotemporal Transcranial Direct Current Stimulation (tDCS) in Hallucinating Patients With Schizophrenia. Brain stimulation 8, 1225\u20131227, doi:10.1016\/j.brs.2015.08.002 (2015).","journal-title":"Brain stimulation"},{"key":"1428_CR72","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","volume":"68","author":"LE Hong","year":"2011","unstructured":"Hong, L. E. et al. Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 68, 1195\u20131206, doi:10.1001\/archgenpsychiatry.2011.83 (2011).","journal-title":"Arch Gen Psychiatry"},{"key":"1428_CR73","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/npp.2011.238","volume":"37","author":"JC Shim","year":"2012","unstructured":"Shim, J. C. et al. Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology 37, 660\u2013668, doi:10.1038\/npp.2011.238 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR74","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/j.1360-0443.1994.tb03744.x","volume":"89","author":"JR Hughes","year":"1994","unstructured":"Hughes, J. R., Higgins, S. T. & Bickel, W. K. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction 89, 1461\u20131470, doi:10.1111\/add.1994.89.issue-11 (1994).","journal-title":"Addiction"},{"key":"1428_CR75","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00213-005-0164-7","volume":"184","author":"ED Levin","year":"2006","unstructured":"Levin, E. D., McClernon, F. J. & Rezvani, A. H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184, 523\u2013539, doi:10.1007\/s00213-005-0164-7 (2006).","journal-title":"Psychopharmacology (Berl)"},{"key":"1428_CR76","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1523\/JNEUROSCI.21-06-01819.2001","volume":"21","author":"B Buisson","year":"2001","unstructured":"Buisson, B. & Bertrand, D. Chronic exposure to nicotine upregulates the human (alpha)4((beta)2 nicotinic acetylcholine receptor function. J Neurosci 21, 1819\u20131829 (2001).","journal-title":"J Neurosci"},{"key":"1428_CR77","doi-asserted-by":"crossref","first-page":"5747","DOI":"10.1523\/JNEUROSCI.17-15-05747.1997","volume":"17","author":"CP Fenster","year":"1997","unstructured":"Fenster, C. P., Rains, M. F., Noerager, B., Quick, M. W. & Lester, R. A. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 17, 5747\u20135759 (1997).","journal-title":"J Neurosci"},{"key":"1428_CR78","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/0304-3940(94)90433-2","volume":"168","author":"BE Hunter","year":"1994","unstructured":"Hunter, B. E., de Fiebre, C. M., Papke, R. L., Kem, W. R. & Meyer, E. M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neuroscience letters 168, 130\u2013134, doi:10.1016\/0304-3940(94)90433-2 (1994).","journal-title":"Neuroscience letters"},{"key":"1428_CR79","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.1021\/jm901692q","volume":"53","author":"C Ghiron","year":"2010","unstructured":"Ghiron, C. et al. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625\/WYE-103914). J Med Chem 53, 4379\u20134389, doi:10.1021\/jm901692q (2010).","journal-title":"J Med Chem"},{"key":"1428_CR80","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/jpet.108.150094","volume":"329","author":"R Roncarati","year":"2009","unstructured":"Roncarati, R. et al. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders. J Pharmacol Exp Ther 329, 459\u2013468, doi:10.1124\/jpet.108.150094 (2009).","journal-title":"J Pharmacol Exp Ther"},{"key":"1428_CR81","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.3390\/ijms13022219","volume":"13","author":"M Pohanka","year":"2012","unstructured":"Pohanka, M. Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology. Int J Mol Sci 13, 2219\u20132238, doi:10.3390\/ijms13022219 (2012).","journal-title":"Int J Mol Sci"},{"key":"1428_CR82","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/npp.2011.299","volume":"37","author":"DH Brunzell","year":"2012","unstructured":"Brunzell, D. H. & McIntosh, J. M. Alpha7 Nicotinic Acetylcholine Receptors Modulate Motivation to Self-Administer Nicotine: Implications for Smoking and Schizophrenia. Neuropsychopharmacology 37, 1134\u20131143, doi:10.1038\/npp.2011.299 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR83","doi-asserted-by":"publisher","first-page":"CC01","DOI":"10.7860\/JCDR\/2015\/16444.6867","volume":"9","author":"HR Vajravelu","year":"2015","unstructured":"Vajravelu, H. R., Gnanadurai, T. K., Krishnan, P. & Ayyavoo, S. Impact of Quantified Smoking Status on Cognition in Young Adults. J Clin Diagn Res 9, CC01\u201303, doi:10.7860\/JCDR\/2015\/16444.6867 (2015).","journal-title":"J Clin Diagn Res"},{"key":"1428_CR84","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2105\/AJPH.93.6.994","volume":"93","author":"M Richards","year":"2003","unstructured":"Richards, M., Jarvis, M. J., Thompson, N. & Wadsworth, M. E. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 93, 994\u2013998, doi:10.2105\/AJPH.93.6.994 (2003).","journal-title":"Am J Public Health"},{"key":"1428_CR85","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/aje\/kwf135","volume":"156","author":"S Kalmijn","year":"2002","unstructured":"Kalmijn, S., van Boxtel, M. P., Verschuren, M. W., Jolles, J. & Launer, L. J. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol 156, 936\u2013944, doi:10.1093\/aje\/kwf135 (2002).","journal-title":"Am J Epidemiol"},{"key":"1428_CR86","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/1462220031000158681","volume":"5","author":"SJ Heishman","year":"2003","unstructured":"Heishman, S. J., Singleton, E. G. & Moolchan, E. T. Tobacco Craving Questionnaire: reliability and validity of a new multifactorial instrument. Nicotine Tob Res 5, 645\u2013654, doi:10.1080\/1462220031000158681 (2003).","journal-title":"Nicotine Tob Res"},{"key":"1428_CR87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","volume":"43","author":"JR Hughes","year":"1986","unstructured":"Hughes, J. R. & Hatsukami, D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43, 289\u2013294, doi:10.1001\/archpsyc.1986.01800030107013 (1986).","journal-title":"Arch Gen Psychiatry"},{"key":"1428_CR88","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/npp.2013.161","volume":"38","author":"TK Rajji","year":"2013","unstructured":"Rajji, T. K. et al. PAS-induced potentiation of cortical-evoked activity in the dorsolateral prefrontal cortex. Neuropsychopharmacology 38, 2545\u20132552, doi:10.1038\/npp.2013.161 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1428_CR89","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fnsys.2015.00173","volume":"9","author":"AH Lara","year":"2015","unstructured":"Lara, A. H. & Wallis, J. D. The Role of Prefrontal Cortex in Working Memory: A Mini Review. Front Syst Neurosci 9, 173, doi:10.3389\/fnsys.2015.00173 (2015).","journal-title":"Front Syst Neurosci"},{"key":"1428_CR90","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00221-008-1642-z","volume":"192","author":"AF Rossi","year":"2009","unstructured":"Rossi, A. F., Pessoa, L., Desimone, R. & Ungerleider, L. G. The prefrontal cortex and the executive control of attention. Experimental brain research 192, 489\u2013497, doi:10.1007\/s00221-008-1642-z (2009).","journal-title":"Experimental brain research"},{"issue":"Pt 7","key":"1428_CR91","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/brain\/121.7.1239","volume":"121","author":"PC Fletcher","year":"1998","unstructured":"Fletcher, P. C., Shallice, T. & Dolan, R. J. The functional roles of prefrontal cortex in episodic memory. I. Encoding. Brain 121(Pt 7), 1239\u20131248, doi:10.1093\/brain\/121.7.1239 (1998).","journal-title":"Brain"},{"issue":"Pt 7","key":"1428_CR92","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/121.7.1249","volume":"121","author":"PC Fletcher","year":"1998","unstructured":"Fletcher, P. C., Shallice, T., Frith, C. D., Frackowiak, R. S. & Dolan, R. J. The functional roles of prefrontal cortex in episodic memory. II. Retrieval. Brain 121(Pt 7), 1249\u20131256, doi:10.1093\/brain\/121.7.1249 (1998).","journal-title":"Retrieval. Brain"},{"key":"1428_CR93","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neuropsychologia.2015.02.028","volume":"74","author":"LB Roy","year":"2015","unstructured":"Roy, L. B., Sparing, R., Fink, G. R. & Hesse, M. D. Modulation of attention functions by anodal tDCS on right PPC. Neuropsychologia 74, 96\u2013107, doi:10.1016\/j.neuropsychologia.2015.02.028 (2015).","journal-title":"Neuropsychologia"},{"key":"1428_CR94","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1162\/jocn_a_00979","volume":"28","author":"J Au","year":"2016","unstructured":"Au, J. et al. Enhancing Working Memory Training with Transcranial Direct Current Stimulation. Journal of cognitive neuroscience 28, 1419\u20131432, doi:10.1162\/jocn_a_00979 (2016).","journal-title":"Journal of cognitive neuroscience"},{"key":"1428_CR95","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1037\/a0025594","volume":"20","author":"RL Ashare","year":"2012","unstructured":"Ashare, R. L. & McKee, S. A. Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. Exp Clin Psychopharmacol 20, 63\u201370, doi:10.1037\/a0025594 (2012).","journal-title":"Exp Clin Psychopharmacol"},{"key":"1428_CR96","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","volume":"65","author":"F Patterson","year":"2009","unstructured":"Patterson, F. et al. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 65, 144\u2013149, doi:10.1016\/j.biopsych.2008.08.028 (2009).","journal-title":"Biol Psychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01428-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01428-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:30:24Z","timestamp":1750206624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-01428-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,3]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-01428-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,3]]},"assertion":[{"value":"13 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.-F. Kuo, J. Grundey and G. Batsikadze received no financial support, and no compensation has been received from any individual or corporate entity over the past 3 years for research or professional service, and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest. A. Hasan has received paid speakership by Desitin and Otsuka and BAK. He was member of a Roche and a Lundbeck Advisory Board. W. Paulus is member of the Advisory Boards of EBS Technologies and Precisis AG. M.A. Nitsche is member of the Advisory Board of Neuroelectronics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1387"}}